Ledger.Open graph →
SEC Form D · Amendment · filed August 3, 2023

Elucida Oncology, Inc

Offering
$22.3M
Sold
$22.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Monmouth Junction, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

David Zacardelli · Monmouth Junction, NJDirectorUlrich Wiesner · Monmouth Junction, NJDirectorNatalie Macdonald · Monmouth Junction, NJDirectorTim Boris · Monmouth Junction, NJDirectorRobert Essner · Monmouth Junction, NJExec · DirectorRobert Ruffolo · Monmouth Junction, NJDirectorGary Sender · Monmouth Junction, NJDirectorGeno Germano · Monmouth Junction, NJExec · DirectorGarheng S. Kong · Alpharetta, GADirectorMichael Wolfgramm · Orem, UTExec · DirectorRalph Yarro · Orem, UTDirectorDaniel R. Myers · Alpharetta, GADirectorPhilip S. Ashman · Alpharetta, GADirectorJohn M. Courtright · Elmhurst, ILDirectorSpencer Patterson · Orem, UTExec · DirectorJonathan R. Simon · New York, NYDirectorJanice Craig · Vancouver, British Columbia, CanadaDirectorDion F. Chu · New York, NYExec · DirectorMichael F. Peng · New York, NYDirectorHelene Servillon · Dover, DEExec · DirectorKara Forney · Albuquerque, NMDirectorDayah Energy GP, LLC · EATONTOWN, NJDirectorDayah Capital LLC · EATONTOWN, NJDirectorTerry J. Thib · Naples, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗